Kamada KMDA
NASDAQ KMDA
$8.02 +0.13 (+1.65%)
At close: Aug 20, 2026 · 4:00 PM EDT

Kamada (KMDA) Net Equity Issued and Repurchased (2013 - 2023)

Kamada's (KMDA) quarterly Net Equity Issued and Repurchased came in at $58.2 million in Q3 2023, up 5823200.0% on a QoQ basis from -$1000.0 in Q3 2020.

Kamada (KMDA) Net Equity Issued and Repurchased (2013 - 2023) Analysis & Trends

Kamada (KMDA) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $58.2 million in Q3 2023.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $58.2 million in Q3 2023, while the trailing twelve-month figure through Dec 2023 was $58.2 million (changed N/A YoY) and the FY2023 annual result came in at $58.2 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased advanced to $58.2 million in Q3 2023, from -$1000.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $58.2 million in Q3 2023 to a low of -$1000.0 in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 700,000.00
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 84.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Kamada 462.32 Mn 432.85 Mn 22.47 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 58.23 Mn
Sep 30, 2023 58.23 Mn
Sep 30, 2020 -1,000.00
Sep 30, 2020 -1,000.00
Mar 31, 2020 24.90 Mn
Mar 31, 2020 24.90 Mn
Dec 31, 2017 10,000.00
Dec 31, 2017 10,000.00
Sep 30, 2017 15.56 Mn
Sep 30, 2017 15.56 Mn
Sep 30, 2013 53.10 Mn
Sep 30, 2013 53.10 Mn
Jun 30, 2013 54.48 Mn
Jun 30, 2013 54.48 Mn